| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 05/02/2001 | EP1095056A1 High pressure refolding of protein aggregates and inclusion bodies |
| 05/02/2001 | EP1095055A1 Method for the production of recombinant peptides with a low amount of trisulfides |
| 05/02/2001 | EP1095054A1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 05/02/2001 | EP1094835A1 Pharmaceutical composition comprising human apotransferrin and process for manufacturing of the composition |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | CN1293201A Process for separating and extracting nisin from fermented liquid |
| 05/01/2001 | US6226603 Method for the prediction of binding targets and the design of ligands |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225445 Fatty acid derivatives of sulfhydryl-containing compounds (for example, sulfhydryl-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage |
| 05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
| 05/01/2001 | US6225072 Process for the extraction of proteins |
| 05/01/2001 | US6225059 Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | CA2075042C Manipulation of solid, semi-solid or liquid materials |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341220C Cloning and characterization of the bovine interleukin-2-gene |
| 04/26/2001 | WO2001029066A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | WO2001029065A1 Process for preparing peptide intermediates |
| 04/26/2001 | WO2001028593A2 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | WO2001028511A2 Selective removal of contaminants from a surface using magnets |
| 04/26/2001 | CA2388700A1 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | CA2388315A1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | CA2387995A1 Process for preparing peptide intermediates |
| 04/25/2001 | EP1094079A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1094078A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1094074A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses |
| 04/25/2001 | EP1094073A2 Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis |
| 04/25/2001 | EP1093720A1 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1093458A1 Process for the preparation of resin-bound cyclic peptides |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1064970C Non-densatured extraction method of medical collagen protein |
| 04/25/2001 | CN1064968C Process for extracting and purifying recombined protein |
| 04/24/2001 | US6222032 Conducting the c-alkylation or n-alkylation reaction in the presence of a slightly nucleophilic strong base comprising a phosphorus compound |
| 04/24/2001 | US6222013 Esterifying amino acid or peptide by mixing with alkanol and chlorosulfonic acid; alcohol reacts with chlorosulfonic acid to form a hydrosulfate which then reacts with amino acid or peptide for form corresponding ester |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | US6221363 Vaccine for the prevention of lyme disease |
| 04/24/2001 | CA2112805C Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained |
| 04/24/2001 | CA2111863C Technetium-99m labeled peptides for imaging |
| 04/24/2001 | CA2002210C Expression and processing of authentic fgf's in yeast |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027293A1 Purification of recombinant proteins fused to multiple epitopes |
| 04/19/2001 | WO2001026455A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| 04/19/2001 | WO2001019846A8 Transgenically produced fusion proteins |
| 04/19/2001 | WO1999061913A3 Improvements in or relating to diagnosis and treatment of bacterial infections |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2382741A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| 04/18/2001 | EP1092036A1 Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091979A1 Seeding crystals for the preparation of peptides or proteins |
| 04/18/2001 | EP0725790B1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 04/18/2001 | CN1291616A Process for separating and purifying high-purity high-activity phycocyanin |
| 04/18/2001 | CN1064690C Shark-cartrilage blood-vessel generation inhibitory factor and separating and purifying method therefor |
| 04/17/2001 | US6219622 Computational method for designing chemical structures having common functional characteristics |
| 04/17/2001 | US6218517 Protein having a vascularization inhibitory effect and a method for production thereof and a method for producing angiostatin |
| 04/17/2001 | US6218508 Anti-microbial proteins |
| 04/17/2001 | US6218505 Amidation step is carried out in the presence of a condensing agent, and ph is controlled to improve yields; chromatographic purification using polyamide resin wherein only aqueous solutions are employed for washings and elution |
| 04/17/2001 | US6218160 Site-specific conjugation of glycoproteins |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6217873 Polyoxime compounds and their preparation |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/12/2001 | WO2001025277A1 Single-chain antagonist polypeptides |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001025172A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2000071570A8 Solid phase peptide synthesis method |
| 04/12/2001 | WO2000064938A3 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 04/12/2001 | WO2000018881A8 Intein mediated peptide ligation |
| 04/12/2001 | WO2000012123A3 Method and measuring device for determining a plurality of analytes in a sample |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2385715A1 A method for preparing and screening one or more compounds |
| 04/11/2001 | EP1090036A2 Site specific protein modification by mutagenesis |
| 04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 04/11/2001 | CN1291199A Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/11/2001 | CN1064370C Process for extraction of plant protein and use |
| 04/10/2001 | US6214984 Nucleic acid coding for a linear heavy chain fragment including repeating variable and constant domains; recombinant production |
| 04/10/2001 | US6214606 Non-chromosomal dna which encodes the protein of defined amino acid sequence; for folding newly synthesized proteins into their biologically active conformation |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214568 Monoclonal antibodies of isotype IgG which bind specifically to glutamate decarboxylase, and uses thereof |
| 04/10/2001 | US6214553 Libraries of protein encoding RNA-protein fusions |
| 04/10/2001 | US6214293 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization |
| 04/10/2001 | US6214221 Method and apparatus for purification of biological substances |
| 04/10/2001 | CA2200855C Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2015769C Production of biologically active polypeptides through treatment with an exogenous peptide sequence |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023413A1 Extracorporeal endotoxin removal method |
| 04/05/2001 | WO2001004265A3 C-terminal protein tagging |
| 04/05/2001 | WO2000053625A3 Microarrays of peptide affinity probes for analyzing gene products and methods for analyzing gene products |
| 04/05/2001 | WO2000036398A9 Method and devices for detecting optical properties, especially luminescence reactions and refraction behaviour of molecules which are directly or indirectly bound on a support |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/04/2001 | EP1088585A2 Method for automated chemical synthesis |
| 04/04/2001 | EP1088020A1 Functionalised polymers of alpha-amino acids and the method of preparation thereof |
| 04/04/2001 | EP1087990A1 Method and apparatus for the production of purified plasma proteins |
| 04/04/2001 | EP1087989A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon |
| 04/04/2001 | EP0648078B1 Purification of zein from corn gluten meal |